Global Alpha 1 Antitrypsin Deficiency Treatment Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 23-Oct-2018
No. of pages: 150

Severe deficiency of alpha-1 antitrypsin (AAT) can cause early-onset emphysema and several liver diseases, including cirrhosis, neonatal hepatitis and hepatocellular carcinoma.

Scope of the Report:

This report focuses on the Alpha 1 Antitrypsin Deficiency Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The discovery of the structure and function of the AAT protein and the subsequent isolation and purification thereof have made possible alternative therapies aimed at preventing the progression of related pulmonary diseases (so-called "additional therapies"). The isolation of this gene and the advancement of gene therapy have further increased the possibility of specific treatment. Most specific treatments for AAT deficiency aim to increase plasma AAT levels (and thus elevated AAT concentrations in the interstitial lung) above the protection threshold. Other experimental therapeutic approaches attempt to interfere with the production of abnormal AAT proteins or to inhibit the polymerization of abnormal AAT proteins and to promote the secretion of AAT from hepatocytes. For patients with end-stage lung disease or liver disease, organ transplantation is another treatment option.

Currently, the most direct and effective way to increase AAT levels in plasma and interstitial lung is by intravenous infusion of pooled alpha-1 antitrypsin (pAAT).

The worldwide market for Alpha 1 Antitrypsin Deficiency Treatment is expected to grow at a CAGR of roughly 9.0% over the next five years, will reach 1980 million US$ in 2023, from 1190 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Pfizer

- Baxter

- AstraZeneca

- Grifols

- Teva Pharmaceutical Industries

- Boehringer Ingelheim

- Kamada Ltd

- GlaxoSmithKline

- CSL Behring

- Shire

- LFB Biomedicaments

- Abeona Therapeutics

- Biogen

- Applied Genetic Technologies

- Baxalta

- Arrowhead Research Corporation

- ProBioGen

- Chiesi Pharmaceuticals

- Curaxys

- ProMetic Life Sciences

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Augmentation Therapy

- Bronchodilators

- Corticosteroids

- Oxygen Therapy

Market Segment by Applications, can be divided into

- Hospitals

- Specialty Clinics

- Pharmacies

There are 15 Chapters to deeply display the global Alpha 1 Antitrypsin Deficiency Treatment market.

Chapter 1, to describe Alpha 1 Antitrypsin Deficiency Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Alpha 1 Antitrypsin Deficiency Treatment, with sales, revenue, and price of Alpha 1 Antitrypsin Deficiency Treatment, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Alpha 1 Antitrypsin Deficiency Treatment, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Alpha 1 Antitrypsin Deficiency Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Alpha 1 Antitrypsin Deficiency Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Alpha 1 Antitrypsin Deficiency Treatment Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Alpha 1 Antitrypsin Deficiency Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Augmentation Therapy
1.2.2 Bronchodilators
1.2.3 Corticosteroids
1.2.4 Oxygen Therapy
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Specialty Clinics
1.3.3 Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Baxter
2.2.1 Business Overview
2.2.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Grifols
2.4.1 Business Overview
2.4.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Teva Pharmaceutical Industries
2.5.1 Business Overview
2.5.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Kamada Ltd
2.7.1 Business Overview
2.7.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 GlaxoSmithKline
2.8.1 Business Overview
2.8.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 CSL Behring
2.9.1 Business Overview
2.9.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Shire
2.10.1 Business Overview
2.10.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Shire Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 LFB Biomedicaments
2.11.1 Business Overview
2.11.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Abeona Therapeutics
2.12.1 Business Overview
2.12.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Biogen
2.13.1 Business Overview
2.13.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Biogen Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Applied Genetic Technologies
2.14.1 Business Overview
2.14.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Baxalta
2.15.1 Business Overview
2.15.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Baxalta Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Arrowhead Research Corporation
2.16.1 Business Overview
2.16.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 ProBioGen
2.17.1 Business Overview
2.17.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Chiesi Pharmaceuticals
2.18.1 Business Overview
2.18.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Curaxys
2.19.1 Business Overview
2.19.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Curaxys Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 ProMetic Life Sciences
2.20.1 Business Overview
2.20.2 Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Alpha 1 Antitrypsin Deficiency Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 Alpha 1 Antitrypsin Deficiency Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Alpha 1 Antitrypsin Deficiency Treatment Market Analysis by Regions
4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
4.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
4.5 South America Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
5 North America Alpha 1 Antitrypsin Deficiency Treatment by Countries
5.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
5.3 Canada Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6 Europe Alpha 1 Antitrypsin Deficiency Treatment by Countries
6.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.3 UK Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.4 France Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.5 Russia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.6 Italy Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment by Countries
7.1 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.3 Japan Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.4 Korea Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.5 India Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
8 South America Alpha 1 Antitrypsin Deficiency Treatment by Countries
8.1 South America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Alpha 1 Antitrypsin Deficiency Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment by Countries
9.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.3 UAE Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
10 Global Alpha 1 Antitrypsin Deficiency Treatment Market Segment by Type
10.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Type (2013-2018)
10.2 Augmentation Therapy Sales Growth and Price
10.2.1 Global Augmentation Therapy Sales Growth (2013-2018)
10.2.2 Global Augmentation Therapy Price (2013-2018)
10.3 Bronchodilators Sales Growth and Price
10.3.1 Global Bronchodilators Sales Growth (2013-2018)
10.3.2 Global Bronchodilators Price (2013-2018)
10.4 Corticosteroids Sales Growth and Price
10.4.1 Global Corticosteroids Sales Growth (2013-2018)
10.4.2 Global Corticosteroids Price (2013-2018)
10.5 Oxygen Therapy Sales Growth and Price
10.5.1 Global Oxygen Therapy Sales Growth (2013-2018)
10.5.2 Global Oxygen Therapy Price (2013-2018)
11 Global Alpha 1 Antitrypsin Deficiency Treatment Market Segment by Application
11.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Specialty Clinics Sales Growth (2013-2018)
11.4 Pharmacies Sales Growth (2013-2018)
12 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.2.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.2.4 South America Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.3 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast by Type (2018-2023)
12.3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Share Forecast by Type (2018-2023)
12.4 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast by Application (2018-2023)
12.4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Alpha 1 Antitrypsin Deficiency Treatment Picture
Table Product Specifications of Alpha 1 Antitrypsin Deficiency Treatment
Figure Global Sales Market Share of Alpha 1 Antitrypsin Deficiency Treatment by Types in 2017
Table Alpha 1 Antitrypsin Deficiency Treatment Types for Major Manufacturers
Figure Augmentation Therapy Picture
Figure Bronchodilators Picture
Figure Corticosteroids Picture
Figure Oxygen Therapy Picture
Figure Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Specialty Clinics Picture
Figure Pharmacies Picture
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure France Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure UK Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure China Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Baxter Basic Information, Manufacturing Base and Competitors
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kamada Ltd Basic Information, Manufacturing Base and Competitors
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Behring Basic Information, Manufacturing Base and Competitors
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table LFB Biomedicaments Basic Information, Manufacturing Base and Competitors
Table LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abeona Therapeutics Basic Information, Manufacturing Base and Competitors
Table Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Biogen Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Applied Genetic Technologies Basic Information, Manufacturing Base and Competitors
Table Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Baxalta Basic Information, Manufacturing Base and Competitors
Table Baxalta Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Baxalta Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Arrowhead Research Corporation Basic Information, Manufacturing Base and Competitors
Table Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ProBioGen Basic Information, Manufacturing Base and Competitors
Table ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Chiesi Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Curaxys Basic Information, Manufacturing Base and Competitors
Table Curaxys Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table Curaxys Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ProMetic Life Sciences Basic Information, Manufacturing Base and Competitors
Table ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Type and Applications
Table ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Figure Top 3 Alpha 1 Antitrypsin Deficiency Treatment Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Alpha 1 Antitrypsin Deficiency Treatment Manufacturer (Revenue) Market Share in 2017
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Regions (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Regions (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Regions (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions in 2013
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions in 2017
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2013
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2017
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2013
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2017
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Canada Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Mexico Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2016
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2017
Figure Germany Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure UK Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure France Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Russia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Italy Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries 2017
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries 2017
Figure China Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Korea Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2017
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2017
Figure Brazil Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Argentina Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Colombia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2017
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2013
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Alpha 1 Antitrypsin Deficiency Tre
  • Global Zinc Lactate Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 123
    Zinc lactate is a zinc salt of lactic acid and commonly used ingredient in toothpaste, mouthwash, chewing gums and other oral hygiene products. Scope of the Report: The demand for zinc lactate has been steadily increasing on the backdrop of increasing health concerns across the globe. The worldwide market for Zinc Lactate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to......
  • Global Tetanus Toxoid Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 123
    Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms. Scope of the Report: US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The worldwide market for Tetanus Toxoid Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. ......
  • Global Mental Illness Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 123
    Mental Illness is a psychological anomaly that is reflected in patient's behavior through disability, distress, or any conduct that is not considered as normal mental development. The causes of mental lllness are very diverse and often unclear in most cases. Scope of the Report: The worldwide market for Mental Illness Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a ne......
  • Global Ovarian Cancer Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 123
    Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body. Scope of the Report: The worldwide market for Ovarian Cancer Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on the Ovarian Cancer Treatmen......
  • Global Pain and Fever Relief Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 120
    The demand for Pain and Fever Relief Drugs will continue to grow in the next few years. Scope of the Report: The worldwide market for Pain and Fever Relief Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on the Pain and Fever Relief Drugs in global market, especially in North America, Europe and Asia-Pac......
  • Global Pediatric Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 137
    The market for pediatric pharmaceuticals has become an increasingly important tool in life-cycle management. However, line extensions using children's formulations to increase patent life of existing adult dose drugs are only one of the drivers of this large, but little-studied market. Scope of the Report: The worldwide market for Pediatric Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in ......
  • Global Pneumonia Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Pneumonia is an infection that inflames the air sacs in one or both lungs. The air sacs may fill with fluid or pus (purulent material), causing cough with phlegm or pus, fever, chills, and difficulty breathing. A variety of organisms, including bacteria, viruses and fungi, can cause pneumonia. Scope of the Report: The worldwide market for Pneumonia Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from ......
  • Global Prostate Cancer Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 117
    Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race. Scope of the Report: The worldwide market for Prostate Cancer Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on the Prostate Cancer Treatment ......
  • Global Tuberculosis Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Nov-2018        Price: US 3480 Onwards        Pages: 122
    Tuberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but they can also damage other parts of the body. TB spreads through the air when a person with TB of the lungs or throat coughs, sneezes, or talks. Scope of the Report: The worldwide market for Tuberculosis Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs